![Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 & Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 &](https://presentations.gsk.com/wp-content/uploads/2022/03/ATS_QR16_Methods.jpg)
Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 &
![Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 & Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 &](https://presentations.gsk.com/wp-content/uploads/2022/03/ATS_QR16_Figure2.png)
Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 &
![Benefits of asthma control treatment regimens. ICs: inhaled corticosteroid. | Download Scientific Diagram Benefits of asthma control treatment regimens. ICs: inhaled corticosteroid. | Download Scientific Diagram](https://www.researchgate.net/publication/358258234/figure/fig3/AS:1131132284342272@1646694360156/Benefits-of-asthma-control-treatment-regimens-ICs-inhaled-corticosteroid.jpg)
Benefits of asthma control treatment regimens. ICs: inhaled corticosteroid. | Download Scientific Diagram
![Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study - ScienceDirect Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095461112200213X-gr2.jpg)
Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study - ScienceDirect
![Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 & Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 &](https://presentations.gsk.com/wp-content/uploads/2022/03/ATS_QR16_Figure3.png)
Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 &
![JCM | Free Full-Text | Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) JCM | Free Full-Text | Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)](https://www.mdpi.com/jcm/jcm-11-06477/article_deploy/html/images/jcm-11-06477-g001-550.jpg)
JCM | Free Full-Text | Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)
![The Salford Lung Study | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder) The Salford Lung Study | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)](https://gskpro.com/content/dam/global/hcpportal/en_IE/relvar/proactive-asthma-control/the-sls/image-1-2nd-tab-2.png)
The Salford Lung Study | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
![New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management | Advances in Therapy New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management | Advances in Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-022-02092-7/MediaObjects/12325_2022_2092_Fig2_HTML.png)
New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management | Advances in Therapy
Hybrid Day 2 - Session 6 - The Power of Proactive Regular Dosing (PRD) in Attaining Asthma Control - Speaker Dr Mohamed Harriss on Vimeo
![Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study - ScienceDirect Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095461112200213X-gr3.jpg)
Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study - ScienceDirect
![Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 & Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 &](https://presentations.gsk.com/wp-content/uploads/2022/03/ATS_QR16_Table1.png)
Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients' and Physicians' peRspectives on the burden and managemENT of asthma studies (APPaRENT 1 &
![Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study - Respiratory Medicine Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study - Respiratory Medicine](https://www.resmedjournal.com/cms/asset/1da0f927-599f-4f72-b36f-be6e7d8da9be/gr1.jpg)
Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study - Respiratory Medicine
![Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic | Advances in Therapy Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic | Advances in Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-022-02056-x/MediaObjects/12325_2022_2056_Fig2_HTML.png)